Download Pharmaceutical Services Unit Essential Medicines Management

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
Pharmaceutical Services Unit
Essential Medicines Management
MoH Procurement of Essential
Medicines
Presented by Mildred Mulenga
Pharmacist, MoH
1
Pharmaceutical Services Unit
Essential Medicines Management
Outline:
 Objectives
 MoH Budget for EMs
 Procurement Cycle
 Factors that influence medicines prices
 Overview of Procurement Methods
 Good Pharmaceutical Procurement Practices
 Organization and Management of
Procurement Unit
2
Pharmaceutical Services Unit
Essential Medicines Management
Objectives:
 To present the MoH Medicines Budget
 To describe the procurement cycle for
EMs
 To present an overview of MoH
Procurement Systems
3
Pharmaceutical Services Unit
Essential Medicines Management
Introduction
 Pharmaceutical procurement system is
major determinant of availability and
total health costs
 GRZ Medicines budget is K590 million
(per capita ZMW47.20)
 18.4 % of total GRZ Health budget
4
Pharmaceutical Services Unit,
DCCDs
National Essential Medicines Budget
Objectives
 ↑ availability and accessibility to all EMs and
medical supplies in all health facilities
5
Pharmaceutical Services
Unit, DCCDs
National Essential Medicines Budget Key
Strengths for 2013:
112% ↑ increase of drug budget from ZMK
270 Billion (2012) to ZMK 594 billion
248% ↑ for ARVs & 20% increase for EMs,
TB, Laboratory, RHCs kits, vaccines, Cancer, Blood
Products and 540% ↑ for medical supplies .
 ZMK
120 Billion for ACTs
6
Pharmaceutical Services Unit,
DCCDs
2013 Budget Key Issues:
 ZMK
28 Billion for medical and surgical supplies
still inadequate in view of the high cost centers of
imaging, sutures, implants, and renal consumables
 New
products ACTs under GRZ budget need
identification of reliable and consistent supply sources
 Huge medicine budget require timely procurement processes
to ↑ budget absorption rates and
↓ lead times
7
Pharmaceutical Services Unit,
DCCDs
2013 Budget Key Implementation Plan
Issues
 Need for timely procurements of all supplies
under Yellow Book
 Regular review of EMLs to improve selection
 Implement all supply chain strengthening
activities to improve availability of Ems
 Implement all rational use of medicines
activities as planned
8
4.5
20
28.8
16.1
19.3
10.0
12.0
60
40
5.4
6.5
120.0
175.0
180
6.2
7.4
7.4
8.9
25.8
31.0
50.2
80
Anti-Retroviral Drugs (↑248%)
ACTs (↑20%)
Vaccines and Immunization Supplies
Tuberculosis Drugs (↑20%)
RH Commodities (↑20%)
Laboratory Reagents (↑20%)
Cancer Drugs (↑20%)
Medical and Surgical Supplies (↑540%
Blood Transfusion Commodities (↑20
9
Hospital Essential Medicines (↑20%)
0
76.2
91.5
100
78.0
93.6
160
ZMK Billions
120
District Essential Medicines (↑20%)
2012
2013
140
2012/2013 National Medicines Budget
Pharmaceutical Services
Unit, DCCDs
2012 National Essential Medicines Budget
District Essential Medicines
28%
Blood Transfusion Commodities
6%
Medical and Surgical Supplies
2%
Cancer Medicines
3%
Laboratory Supplies
2%
Reproductive Health Commodities
2%
TB Medicines
3%
Vaccines
9%
Hospital Essential Medicines
27%
ARVs
18%
10
Pharmaceutical Services
Unit, DCCDs
2013 National Essential Medicines Budget
Hospital Essential Medicines
15%
District Essential Medicines
16%
Blood Transfusion Commodities
3%
Medical and Surgical Supplies
5%
Cancer Medicines
2%
Laboratory Supplies
1%
Reproductive Health Commodities
1%
TB Medicines
2%
Vaccines
5%
ACTs
20%
ARVs
30%
11
Pharmaceutical Services Unit
Essential Medicines Management
2013 National ARV Drug Budget
US$35m , 25%
US$58,3m,
42%
US$45,4m
33%
USG
GF
GRZ
12
Pharmaceutical Services Unit
Essential Medicines Management
Features of Effective Procurement
Process
 procure right medicines
 high quality
 lowest possible price
 timely delivery
 Transparent & written procedures
 separation of key functions
 Reliable payment & good financial
management
 Product quality assurance programme
 Performance monitoring
13
Pharmaceutical Services Unit
Essential Medicines Management
MoH Procurement Cycle
 Review medicines selection
 Quantification
 Reconcile needs and budget
 Select procurement method
 Locate and select suppliers
 Specify contract terms
 Monitor order status
 Receive and check medicines
 Effect payment
 Distribute drugs
 Collect consumption data
14
Pharmaceutical Services Unit
Essential Medicines Management
Factors influencing Drug Prices &
Total costs
 Unit Prices
 Purchasing models
 Visible & hidden costs
15
Pharmaceutical Services Unit
Essential Medicines Management
Overview of Procurement Methods
 Open Tender (ICB or NCB)
 Restricted Tender (closed/selective)
 Competitive negotiations
 Direct Procurement
16
Pharmaceutical Services Unit
Essential Medicines Management
Good Pharmaceutical Procurement
Practices:
 Procurement by Generic name
 NEML
 Bulky procurement
 Formal supplier Qualification (screening)
 Competitive procurement
 Orders based on reliable needs
 Reliable payments
17
Pharmaceutical Services Unit
Essential Medicines Management
Good Pharmaceutical Procurement
Prices cont.
 Transparency and written procedures
 Separation of key functions
 Production quality assurance (WHO
certification & post marketing
surveillance)
 Monitoring (auditing systems in place)
18
Pharmaceutical Services Unit
Essential Medicines Management
Organisation and Management of
Procurement System for EMs at
MoH
 Independent unit with Head PSU
 Chief Procurement Officer,
Pharmaceuticals
19
Pharmaceutical Services Unit
Essential Medicines Management
Responsibilities in the Procurement
Process
 PSU
 ZPPA
 MTCs (Medicines and Therapeutics
Committees)
20
THANK YOU
FOR
LISTENING.
21